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ABSTRACT: Heme is essential for the survival of virtually all
living systemsfrom bacteria, fungi, and yeast, through plants to
animals. No eukaryote has been identified that can survive without
heme. There are thousands of different proteins that require heme
in order to function properly, and these are responsible for
processes such as oxygen transport, electron transfer, oxidative
stress response, respiration, and catalysis. Further to this, in the
past few years, heme has been shown to have an important
regulatory role in cells, in processes such as transcription,
regulation of the circadian clock, and the gating of ion channels. To act in a regulatory capacity, heme needs to move from its
place of synthesis (in mitochondria) to other locations in cells. But while there is detailed information on how the heme lifecycle
begins (heme synthesis), and how it ends (heme degradation), what happens in between is largely a mystery. Here we summarize
recent information on the quantification of heme in cells, and we present a discussion of a mechanistic framework that could meet
the logistical challenge of heme distribution.
KEYWORDS: heme, heme quantification, heme trafficking, heme homeostasis, heme sensors
■ INTRODUCTION
Heme is a macrocyclic complex of iron, with the metal ion
coordinated equatorially to the four nitrogen atoms of an
electronically delocalized protoporphyrin IX ring (Figure 1A)
and to one or two axial ligands. Broadly following an IUPAC
convention that defines heme as a complex of iron coordinated
to a porphyrin and to one or two axial ligands,1 the term heme
is used widely, and often interchangeably, to refer to different
types of iron protoporphyrin IX where the precise heme
structure (e.g., heme a, heme b, heme c, heme d, etc.) is not
always elaborated. When one of these heme structures is
bound to a protein, the two axial ligation positions are
normally occupied by donor ligands provided by protein amino
acids. Heme ligation to the side chains of His, Cys, Met, Tyr,
Lys, Glu residues and even the N-terminus is known.2,3 In
binding to a protein in this way, the heme becomes either 5- or
6-coordinated, Figure 1B. By convention, the proximal
position, which is most commonly a histidine, is assigned as
the fifth ligand and is normally shown underneath the heme
when visualizing heme structures. The sixth ligand, if there is
one, is then drawn above the heme on the so-called distal side.
This proximal/distal terminology dates back at least as far as
the crystallography studies of Kendrew and Perutz.4,5 The
distal position can be occupied by a protein amino acid; by a
diatomic gas (e.g., O2, NO, CO); by water, hydroxide, or
another small molecule ligand (e.g., H2S, CN
−); or it can be
vacant giving a 5-coordinate heme species. The reactivity of the
heme is controlled in part by the number and identity of these
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Figure 1. (A) The structure of iron protoporphyrin IX, also known as
heme b. While heme is mostly hydrophobic, the carboxylate groups
enable hydrogen-bonding interactions between the heme group and
other molecules, including assisting the binding of heme to a protein.
(B) The heme group is classified as containing distal and proximal
sides, which are conventionally drawn above and below the plane of
the ring, respectively. In heme proteins, the proximal side is usually
bound to an amino acid residue provided by the protein; this helps to
control its reactivity as a redox center190,191 and its properties as a gas-
binding molecule for storage and signaling.11
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ligands at the proximal and distal positions, while stabilization
of the heme molecule is further controlled by the heme-
binding pocket via hydrophobic interactions with the
porphyrin ring and vinyl groups, and hydrogen bonds between
the propionate groups and the solvent.6
The role of the protein can thus be envisaged as solubilizing
the hydrophobic and thus poorly soluble heme molecule, and
in doing so controlling the reactivity of the heme group for
biological purposes. Over the past several decades, most of
what has been learned about the role of heme in biology relates
to binding of heme to individual proteins such as those
involved in oxygen transport (e.g., myoglobin, hemoglobin)
and sensing (e.g., cytoglobin, neuroglobin),7 bioenergetics
(e.g., cytochrome c, cytochrome c oxidase),6 metabolism and
catalysis driven by the insertion of oxygen (e.g., cytochrome
P450, indoleamine 2,3-dioxygenase),6 peroxidase catalysis,8
formation of nitric oxide,9 and lipid metabolism (e.g., COX-
2).10
In addition to these widely known roles for heme in biology,
there is now a substantial body of evidence that identifies heme
as a regulator of various cellular activities.11−16 The first report,
to our knowledge, of heme as a regulator was as far back as
1975, when heme was observed as regulating the synthesis of
δ-aminolevulinic acid synthase which catalyzes the first step of
the 8-step heme biosynthesis pathway.17 We see chemical logic
in the concept of regulatory mechanisms in cells that are linked
to heme binding, but the idea of heme as a regulator laid
dormant in the literature for many years. Despite its toxicity
Figure 2. The possible interconnected pathways for the movements of heme in cells, and the links to signaling gases such as CO and NO. From the
total heme synthesized in the cell (top), a proportion is bound irreversibly to heme-binding housekeeping proteins (red circles) that are essential
for cell survival. A body of exchangeable heme is envisaged as being mostly weakly bound, soon after heme biosynthesis, to heme-binding partners
(dark gray pacmans in this and other figures, which could be heme proteins or non-heme proteins) and available for exchange to heme dependent
regulatory proteins (R, right). These heme-binding partners constitute an exchangeable, buffered, reservoir that can provide a flexible supply of
heme and protect against changes in heme concentration. Once formed, these heme-bound proteins can serve in regulatory roles by, for example,
binding to DNA for transcriptional control (top right; including the regulation of heme biosynthesis17,21,28,37,192−194) or to ion channels (middle
and bottom right54,195). In green circles are shown the proteins that produce cell signaling gasesnitric oxide synthase (NOS, left) and heme
oxygenase (NOS, middle). The synthesis of NO by NOS, and the production of CO by the heme degrading HO enzyme, adds multiple layers of
complexity by coupling the formation of cell signaling gases to the heme-binding process. This would allow both CO and NO to bind to any heme
protein with a regulatory function (bottom right) but could equally well occur for other heme dependent regulatory processes. It is worth noting
that, while the binding of π-acid ligands like CO is traditionally associated exclusively with heme in its ferrous form, ferric heme has also been
shown capable of binding CO/NO.41 For the purposes of this review, movement of ferric/ferrous heme is presumed to mean heme b.
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and lack of solubility, heme has a number of redeeming
features that make it easier to understand why it could regulate
cellular functions. The first is that heme is redox active and can
respond to the redox status of the cell by modulating its
oxidation state. The concentration of heme in cells is
controlled by the balance of heme biosynthesis (to increase
heme concentrations) and heme oxygenase activity (which
degrades heme and produces CO as a byproduct). Cell
signaling gases, such as O2, NO, and CO, can bind rapidly and
sometimes reversibly to hemethis could be exploited
alongside the association of heme with a protein to create a
second layer of regulatory control. CO is itself produced via
degradation of heme by the O2-dependent heme oxygenase
enzyme,18−20 and NO is produced by the heme- and O2-
dependent NO synthase enzyme;9 i.e., the production of cell
signaling gases also depends on the presence of heme. We
envisage that the redox state of the cell, the oxidation state of
the heme, the balance between heme synthesis and
degradation, and the relative concentrations of O2, NO, and
CO may all be interconnected as outlined in Figure 2. This
could be used as a versatile mechanism for cell signaling.
Examples of heme-dependent regulation are beyond the scope
of this review but have been summarized recently.11,12 They
include, among others, transcriptional regulation and gas
sensing,11,12,15 degradation of the p53 protein,21 regulation of
the circadian clock,22−42 immune response,43,44 aging,45 and
the gating of numerous ion channels.46−69
■ THE BIOLOGICAL NEED FOR HEME DISTRIBUTION
The fundamental requirement for heme across virtually all
organismsboth in catalytic and regulatory roles as outlined
abovemeans that cells need mechanisms to manage heme
supply and distribution. Supply of heme is regulated by the
well-studied heme biosynthesis pathway.70 At the other end of
the heme lifecycle, surplus heme (when it exists) is degraded
by the O2-dependent heme oxygenase enzyme.
18,19 But while
the enzymatic machinery for making heme−heme synthesis
and removing heme−heme degradationis well established,
what happens in between is almost completely unknown. It has
been recognized as far back as the 1970s71,72 that cells need a
supply of heme to respond to cellular demands, but until quite
recently tools to examine this question have been lacking. In
this review, we outline recent advances in the development of
methods for measuring heme in cells, and we present ideas on,
and possible mechanisms for, heme mobilization consistent
with quantitative determinations of heme concentration.
■ TERMINOLOGY
To begin the discussion, we describe and define the
terminology. For the purposes of this review, we take heme
(in the context of heme transport) to mean heme b. Literature
on the role and distributions of heme in cells has used a
bewildering, and at times imprecise, range of terminologies.
Phrases such as “labile heme”, “regulatory heme”, “free heme”,
and “heme pool” are all used in the literature, often
interchangeably.73 While the need to discriminate between
these types of heme in cells is obvious, it is challenging to
provide a precise description of each. What does “labile heme”
mean? How can “free heme” exist in the cell, given that heme is
cytotoxic and poorly soluble? Does the phrase “regulatory
heme” describe a supply of heme dedicated exclusively for
regulatory purposes, or might it be used for other purposes?
Given its insolubility and cytotoxicity, does it actually make
sense to talk about “pools” of heme when current estimates for
heme concentration are in the nM to μM range?74−79 The lack
of precise descriptions for the nature of different types of heme
can lead to confusing or contradictory interpretations. Below
we provide a summary and offer some suggestions, which we
hope will be helpful in future discussions for both specialists
and newcomers to the field.
Regulatory Heme
In disciplines that vary from blood disorder (e.g., porphy-
ria),80,81 gene expression,71,72 and heme biosynthesis,82,83 a
small portion of the total heme content of the cell has been
referred to over many years as being present in a regulatory or
intracellular heme pool. These terms originate from early
papers71,72,83−86 where it was also suggested that the nature of
heme was a free molecule (see below). The existence of a form
of regulatory heme is conceptually useful, and because of this
the nature of regulatory heme has been debated as long ago as
1975 when new roles for hemeabove and beyond the
traditional roles in oxygen binding, electron transfer, and
catalysiswere identified by Granick.83 In Granick’s work, the
regulation of heme biosynthesis was proposed as being
controlled by fluctuations in the concentrations of heme in a
dedicated heme pool where heme was envisaged as being
weakly associated with an ensemble of cytosolic proteins.83,87
These weak binding interactions were considered important
for heme to be readily exchangeable.83,86 The terms were then
later adopted by scientists in multiple fields.46,80,88−98 Hence,
since Granick’s initial studies, the phrases “regulatory heme”
and “free heme” have been widely used although not precisely
defined.
Free Heme
To the best of our knowledge, the term free heme was
introduced in the 1970s72,85,99 and was interpreted as an
intracellular population of free heme molecules either on their
own (free) or all together (in a pool). These early papers noted
the difficulties associated with the idea of a pool of free heme,
but, nevertheless, the concept and the terms “free heme” and
“pool of free heme” became ingrained in the litera-
ture.85,92,94,95,100,101 The term “free heme” has never been
precisely definedbroadly speaking it has been taken to mean
a heme molecule that is not bound to anything else. There are
difficulties with that idea, however, and the concept of large
amounts of free heme, because heme is cytotoxic through
Fenton chemistry and radical formation.92,94,96,102−104 So if
heme is free in the cells, it would cause problems. Heme is also
a hydrophobic molecule and poorly soluble, so presumably
cannot exist in cells without being solubilized by binding to a
protein, cellular membranes,105 or even nucleic acids.45,106
Moreover, heme needs to be ligated at the fifth and sixth
ligation position, otherwise, it will stack to form dimers, or
higher multimers, in solution.107,108 This is problematic for
cellular handing because, in a dimeric or multimeric form,
heme could not be delivered to proteins that require only one
molecule per binding site.
We envisage that a “free” molecule of heme can therefore
only exist transiently in cells. In this review, we will use the
term “free heme” to indicate molecules of iron protoporphyrin
IX, in the ferrous or ferric oxidation state, existing in the
absence of any protein binding partner but weakly associated
with water molecules as ligands at the fifth and sixth
coordination sites.
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Labile Heme
In recent years the term “ labile heme” has ap-
peared.44,78,96,105,109−120 The use of this term allows a
distinction to be made between the proportion of the total
heme content that is available for mobilization, and the
proportion that is unavailable (or, more precisely, inert for
exchange) because it is bound with a high affinity, and
therefore irreversibly, to proteins. Ideas on what the concepts
of labile heme actually means mimic the early ideas on free
heme.83,87 Labile heme is envisaged as being continuously
engaged in transient binding to intracellular proteins that exist
to actively buffer heme concentrations in the cell. Since some
heme is unavailable for distribution in cells, labile heme is thus
envisaged as a intermediary through which heme can move and
be distributed through the cell.105,110−112 The term labile heme
probably finds its origins as an adaptation of “labile iron pool”
that predated it.121
Exchangeable Heme
The use of the term lability to distinguish a more mobile
fraction of the total heme from that which is permanently
(irreversibly) embedded into heme proteins is similar in
concept to the kinetic lability of ligands in inorganic metal
complexes.122−124 Labile ligands exchange very fast, and inert
ligands exchange slowly. But the availability and distribution of
heme will be defined not just by the kinetic lability of the
ligands bound to the heme, but also by thermodynamics. This
is because cascades of heme exchange events down a
thermodynamic gradient (dictated by heme binding affinity)
will control the overall distribution of heme. Hence, our
opinion is that “exchangeable heme”which has been adopted
in a limited number of examples77,86,97,125is a more precise
term to convey the concept that both kinetic and
thermodynamic processes are relevant when considering the
bioavailability of heme.
Definitions Used in This Review
We propose here a working set of definitions.
Total Heme (Ht). The total heme content of a cell. This
includes the fraction of heme that is bound irreversibly to
proteins and thus not available for other purposes (defined
here as Hh), and the fraction of exchangeable heme (which
includes small quantities of free heme, see below).
Exchangeable Heme (He). A fraction of the total heme
that is reversibly bound to proteins or small ligand molecules
(e.g., free amino acids, H2O). Exchangeable heme can be
considered as a reservoir that provides an accessible supply of
heme to the cell.
Free Heme (Hf). Molecules of heme that are not bound to
a protein but weakly coordinated with water molecules. We
expect free heme to exist in vanishingly small quantities. Long
and co-workers126 have recently offered a definition for free
heme which is similar to that proposed here.
Figure 3. Representation of possible mechanisms for distribution and delivery of heme across the cell. (A) The life cycle of heme in cells starts with
its biosynthesis in the mitochondria (full dashed square) and ends with its degradation by heme oxygenase (HO-1/2). Heme oxygenase generates
Fe2+ which can be recycled for the synthesis of new heme molecules. A balance between synthesis and degradation contributes to the controlling
heme concentrations in cells. (B−E) The supply of heme to the locations where it is in demand is suggested as occurring via four possible
mechanisms (colored panels). In (B), direct distribution of free heme into a heme protein (red circle), a heme-dependent regulatory function (R,
white box), or a genetically encoded/synthetic heme sensor for quantification studies (S, green circle). Free heme (either ferrous or ferric) is
envisaged as being present in minuscule concentrations but will still represent a mechanism for heme to be made available in cells.77 In (C),
chaperone-mediated heme delivery to an apo-heme protein (pale red circle), for example by GAPDH.113−115 In (D), heme bound to heme-binding
partners (dark gray pacman) constitutes a body of exchangeable heme readily available for downstream applications, in the same way as in (B).
Possible candidates for heme-binding proteins are IDO, HBP22/23, SOUL, and albumin.111,163,196 In (E), distribution of heme via membrane
contact sites between mitochondriawhere heme is synthesizedto target cellular compartments which bypasses the need for transporters to
mediate the delivery of heme.171
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In principle, Ht = Hh + He + Hf, where Hh is the amount of
heme that is bound irreversibly to heme proteins (including
membrane and cytosolic proteins).
■ THE LOGISTICS OF HEME SUPPLY AND DEMAND
Given the need to move heme from its place of synthesis (in
the mitochondria) to other regions of the cell, how can cells
control the balance of supply and demand and what
mechanisms are in place to do this?
Controlling Supply and Demand
The balance between heme biosynthesis and degradation is
part of the regulatory control that the cell needs to maintain
heme availability below the cytotoxic threshold (Figure
3A).94,102,127 Heme oxygenase, whose mechanism of degrada-
tion of heme into biliverdin and CO is well-known,18,19 plays a
crucial role in maintaining this balance. Heme oxygenase-1 is
transcriptionally regulated and induced by infection, inflam-
mation, oxidative stress or increasing concentrations of
heme.128,129 Interestingly, the post-transcriptional regulation
of heme oxygenase-2 (abundant in the brain, testes, and neural
tissue) has been shown to be controlled by heme occupancy in
the active site.130 Specifically, heme oxygenase-2 appears to be
destabilized and more likely to be degraded when heme is not
bound, which is the likely situation under conditions of heme
deficiency and when high heme oxygenase activity is
undesirable. This regulation would help to keep heme
concentrations within a suitable physiological range under
conditions of cellular heme deficiency.130
The Involvement of Heme Chaperones
The existence of biological chaperone systems is documented
for other redox active transition metal ions (e.g., iron, copper,
molybdenum, cobalt, nickel).131−134 Cells adopt strategies to
tightly regulate the concentrations of different metals ions,
ensuring suitable levels of bioavailability, effective physiological
responses, and prevention of cytotoxicity.133−149 The concen-
tration of transition metal ions in cells is kept at very low levels
to avoid inappropriate activation of signaling pathways. For
instance, the intracellular free copper concentration in
S. cerevisiae is limited to less than one molecule per
cell.133,137 Similarly, free zinc is estimated in the low
femtomolar range in E. coli.133,136 Instead of being free to
circulate around the cell, metal ions are stored, locked in an
inaccessible state, and released to a network of chaperones or
chelators that control their delivery, repurposing, and ensure
fidelity in metalation when two competitive metals can bind to
the same site.134,138−144 By comparison, it is reasonable to
presume that cells use similar principles for the movement and
distribution of free heme (Figure 3C,D).
The identification of heme chaperones with the specific role
of transporting and selectively delivering heme to downstream
proteins would thus clarify the picture considerably. But very
few heme chaperones have been identified over the years. A
notable example is the CcmE chaperone, part of the multi
component Ccm membrane heme maturation machinery for
heme translocation to cytochrome c in most proteobacteria,
archaea, deinococcales, and plant mitochondria.150−153 How-
ever, this is a special case as it speaks only to the need for
formation of covalent links to heme in the specialized c-type
cytochromes. GAPDH is perhaps the most compelling example
of a heme chaperone so far identified.113−115,154 The
interaction between GAPDH and heme was initially thought
to occur to protect heme from degradation during its transport
(which at the same time reduces its cytotoxicity).155 But
GAPDH has since been found to be responsible for the
delivery of heme to the nuclear transcription factor Hap1156 in
S. cerevisiae, to cytosolic iNOS in mouse macrophage cells,113
and to soluble guanylate cyclase in HEK293 cells.114
The involvement of GAPDH in heme delivery in both yeast
and mammalian systems is indicative of a broadly conserved
strategy for heme transport.113 GAPDH is primarily a
glycolytic enzyme, and, therefore, its function as a heme
chaperone looks to be opportunistic as far as the cell is
concerned. This begs the question as to whether there are
other as-yet unidentified heme chaperones lurking about the
cell in disguise. Certainly, if heme chaperones are used at all
then more than one could be required to create an effective
supply chain. Arguably, chaperones of chaperones might even
exist.115 But if heme binding can be opportunistic and does not
need a specific heme-binding motifas GAPDH seems to
indicatethen identification of heme chaperones becomes an
incredibly demanding task which would need to take into
account noncanonical heme-binding motifs in addition to the
large number of proteins with known heme-binding sites.3,157
All of this leads us to the conclusion that existing, well-
known heme-binding proteins could be repurposed for the task
of cellular heme delivery under certain conditions. For
example, indoleamine 2,3-dioxygenase, whose mechanism
and structure is well-documented,158−162 has recently been
shown to lose its heme under certain conditions,163 which
suggests the possibility that it could be used as a source of
heme in specific regions of cells. In all likelihood, there may be
other cellular proteins that can similarly masquerade as heme
chaperones.
Possible Limitations on the Utility of Chaperones for the
Distribution of Heme
The distribution of heme via chaperones can be used to explain
how heme moves from the mitochondria to other locations,
and then subsequently to the endoplasmic reticulum for
degradation by heme oxygenase. But the chaperone mecha-
nism is ill-equipped to deal with rapid changes in heme
availability. If increases or decreases in heme concentration are
required, then the rate-limiting steps are heme synthesis and
degradation. Upregulation of heme synthesis, by expression of
the ALA synthase enzyme, in response to low heme availability
could take at least 30 min,164 while induction of heme
oxygenase-1 for heme degradation could take hours.165 Both of
these mechanisms are too slow by far if rapid control of heme
concentration is required, for example in the case of ion
channel regulation which is necessary for appropriate cardiac
function.54 Hence, if the cell is solely reliant on heme
chaperones, then it runs the risk of spikes in heme availability
should there be a mismatch in timings between the delivery
and the removal of heme. Taken together, and bearing in mind
the failure (so far) to identify large numbers of heme
chaperones, we suggest that complementary mechanisms will
be required to regulate heme distribution. We elaborate on this
below.
Buffering of Free Heme Concentration as a Mechanism of
Control
An ability to store heme in cells would decrease the reliance of
cells on heme synthesis and degradation and could be coupled
to mechanisms to make heme more or less available, on-
demand and at speed (Figure 3D). To date, there have been
no proteins identified that have the dedicated function of
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storing heme, but there is evidence, from recent work,77 of a
buffering capacity within cells that can accommodate changes
in either the total concentration of heme (i.e., [Ht]), or the
concentration of exchangeable heme (i.e., [He]), while
maintain the capability to mobilize heme as and when
necessary. As indicated above, it is entirely possible that
known heme proteins (such as indoleamine 2,3-dioxygenase,
and GAPDH) participate in the buffering of free heme
concentration ([Hf]) and protect the cell against increases or
decreases in total, or exchangeable, heme concentration. In this
scenario for heme buffering, the ability of any given protein to
acquire heme is based on how well it competes for heme (i.e.,
the heme affinity) against other proteins. Hence the availability
of heme in the cell would be dependent entirely on the Kd, and
abundance, of these heme-binding partners. In this way, the
concentration of free heme is bufferedor, in other words, the
availability of heme is kept within a limited rangeby the
many heme-binding proteins in the buffer and would be
distributed among those proteins according to their relative
heme affinities.
Crucially, in this buffering model the hierarchy of heme-
binding affinity would be responsive to changes in the
composition of the buffering proteins. As an example,
upregulation of proteins in the buffer with high heme affinity
(e.g., a globin, or a cytochrome) would deplete the capacity of
the exchangeable heme reservoir to release heme, as heme was
dragged to thermodynamically inaccessible sites. As well as
providing a reservoir of exchangeable heme able to meet the
localized and instantaneous demands of the cell, such a
buffering system would, along with the heme degradation
pathways, prevent heme-induced cytotoxicity by limiting the
concentrations of free heme within the cell. The interplay
between heme biosynthesis, degradation, transcriptional and
post-transcriptional regulation of heme buffering proteins, are
all envisaged as jointly contributing to the buffering of heme in
cells.
Trafficking through Membranes
Evidence is emerging for the involvement of biological
membranes as important factors in the trafficking of cellular
heme. Heme has been shown to be capable of diffusing or even
being retained by cellular lipid bilayers166−168 and examples of
putative membrane heme transporters have been identified,
most notably the mitochondrial exporter Flvcr1b, which have
been reviewed elsewhere.94,169 But while heme may or may not
necessitate membrane transporters for its movement across
compartments, the contribution of lipid bilayers to heme
trafficking is still not completely clarified. A recent study has
proposed that the trafficking of heme through membranes does
not rely on transporters and is, in contrast, a chaperone-less
pathway made possible by interorganellar contact sites. This
provides an elegant solution for the exchange of heme between
compartments (Figure 3E).170,171
■ QUANTIFYING HEME CONCENTRATIONS IN
CELLS
Early Estimation of Heme Concentration
Granick speculated in the 1970s83,87 that the concentration of
exchangeable heme in the cytosol was in the range 10−100
nM. This value is, in fact, remarkably close to recent
measurements (Table 1). In the past, the cellular heme
concentration has had to be inferred from the amount of heme
measured in soluble cell lysis extracts determined using either
fluorometric approaches172 or enzymatic reconstitution







concentration (nM) quantitation method tested in ref.
CYSDY-9 IsdX1, IsdC ECFP, EYFP 63.5 ± 14.3 Cytosol 25.6 ± 5.5 FRET HeLa 76
Mitochondria 23.3 ± 4.9
Nucleus 31.0 ± 7.0
ER 5.4 ± 1.4c










ECFP, EYFP ∼250 Cytosol 1600 FRET P. falciparum 78
apo-HRP Horseradish
peroxidase











− 270 ± 40 433 ± 125 Reconstitution of
catalytic activityd
HEK293 75
mAPXmEGFPe Ascorbate peroxidase mEGFP 22 Cytosol 4 RET HEK293 77
aThe heme affinity, or conversely the dissociation constant Kd,heme, is a key parameter in heme quantitation. Kd,heme values should be close to the
physiological concentrations of heme (in the nM to μM range), to ensure prompt response of the sensor to changes in [heme] but also avoiding the
sensor becoming either fully saturated or fully unsaturated (which is essential to study dynamic cellular processes). Kd,heme defines the fraction of
total cellular heme which is available for donor−acceptor heme exchange (acceptor = apo-heme sensor). Heme sensors with the highest heme
affinities will accept heme from a larger ensemble of heme donors, and vice versa. Caution is needed when comparing heme concentrations
obtained with different sensors, as the sensors with lower Kd,heme will draw heme from a larger number of donors.
bFor ferric heme unless otherwise
stated. cA relatively low concentration of heme was measured in the endoplasmic reticulum of HeLa cells compared to other cell lines (mouse
melanoma B16, human HCT116 colon cancer cell, human PANC-1, hamster kidney fibroblast BHK-21, and CHO), which was interpreted as due
to the high expression levels of heme oxygenase-1 in the endoplasmic reticulum surface of HeLa cells. dholo-HRP was formed by mixing apo-HRP
with HEK293 lysates. The reconstitution of the catalytic activity of the HRP reporter by its binding to cellular heme was then used to measure
heme concentration. emAPX = monomeric APX; mEGFP = monomeric EGFP.
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techniques.74,89,97,173 These methods are likely to report a
concentration that lies somewhere between that for exchange-
able heme ([He]) and the total amount of heme present in the
cell ([Ht]) because the denaturing methods lead to release of
heme from many heme proteins. In order to selectively
measure concentrations of exchangeable heme, it is necessary
to use a method that is compatible with in vivo fluorescence
imaging or spectroscopy of live cells.174 Such an approach is
possible by the design and application of genetically encoded
Figure 4. Basic principles of heme sensor designs. (A) RET sensors: Heme-binding to this type of sensor introduces an additional relaxation
pathway for the electronic excited state of the fluorophore. The mean fluorescence lifetime of the probe changes between the limiting values of τapo
to τholo for the pure apo and holo forms of the sensor dependent on heme concentration.
77 (B) FRET sensors: The heme-binding domain of the
sensor undergoes a conformational change that brings two fluorophores into close proximity to one another. In this example, Förster energy
transfer results in a decrease in the emission of a green fluorophore and an increase in emission of a yellow fluorophore. Hence changes in the
relative emission intensities of the two fluorophores can be used to determine heme concentration.76 Multiple heme-binding sites may be present in
the heme-binding domain.78 (C) A RET sensor (similar to that shown in (A)) that incorporates an additional fluorophore in order to measure a
ratiometric intensity. The sensor is composed of two fluorophores, but heme-binding triggers the selective quenching of the fluorescence of only
one of them. The unperturbed tag can then be used as an internal reference to monitor the changes in the intensity of emission for the quenched
fluorophore, providing a method for precise heme quantitation.79,112
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heme sensors which can be expressed recombinantly in
different cell lines.
The Development of Cellular Heme Sensors
Genetically encoded sensors comprise a heme-binding protein
conjugated to one or more fluorescent proteins. For the sensor
to report on the presence and quantify the concentration of
heme, the fluorescence output must be modulated by heme
binding. There are different mechanisms that can lead to
suitable modulation of the fluorescence output.
a. Förster Resonance-Energy Transfer between the
Fluorescent Protein and a Bound Molecule of Heme.
The heme-binding pocket of the sensor must be located in
close proximity to the chromophore-forming amino acids in
the fluorescent protein, and the emission of the fluorescent
protein must have spectral overlap with either the Soret or Q
absorption bands of heme.175 In this case, resonance-energy
transfer provides a nonradiative decay pathway for the
photoexcited state of the chromophore, via the heme moiety,
that competes with the radiative-decay pathway responsible for
the fluorescence signal (Figure 4A,C).
b. Förster Resonance-Energy Transfer between a Pair
of Fluorescent Proteins. Unlike in (a), the heme-binding
pocket must be distant from both fluorescent proteins, and,
instead, the binding of heme to the sensor must lead to a
conformational change that brings the chromophore-forming
amino acids on each of the fluorescent proteins (i.e., the donor
and acceptor sites) into close proximity; see Figure 4B. In this
case, resonance-energy transfer between the donor and
acceptor leads to subsequent radiative decay from the acceptor.
Hence the binding of a molecule of heme is detected by the
attenuation of the short wavelength emission band of one the
fluorescent proteins (the donor), and the appearance of the
long wavelength emission band of the other fluorescent protein
(the acceptor).
In order to distinguish between the mode of operation of
these two different designs for heme sensors, we will refer to
the mechanism described in (a) as just resonance-energy
transfer (RET) and the mechanism described in (b) as
fluorescence resonance-energy transfer (FRET).
Further consideration is given here to the heme sensor
design comprising a heme-binding domain and a single
fluorescent protein (i.e., that shown in Figure 4A). If the
distance between the chromophore-forming amino acids on
the fluorescent protein and the heme-binding pocket, r, is
much less than the Förster distance, R0 (calculated from the
spectral overlap integral175), then the efficiency of RET in the
holo-sensor will be near to 100%. The fluorescence quantum
yield of the holo-sensor (i.e., the sensor with heme bound to it)
will be near to 0%, and the presence of heme can be inferred
from the quenching of the intensity of the fluorescence
emission. Alternatively, if the distance r is close to the R0, then
there will be an intermediate efficiency for RET in the holo-
sensor (given by 100% × 1/(1 + (r/R0)
6). The fluorescence
quantum yield of the holo-sensor will be reduced (but will not
equal zero), and the presence of heme can be inferred from
either the reduction in the emission intensity or from a
reduction in the fluorescence lifetime.
A change in the fluorescence lifetime can be observed by
time-correlated single photon counting, where the proportions
of the apo- and holo-forms of the sensor can also be deduced
by determining the relative amplitudes of functions in the
fitting of a multiexponential decay model, Figure 4A. For a
genetically encoded heme sensor, a measurement of a
fluorescence decay profile has significant advantages over a
measurement of fluorescence intensity: (i) The fluorescence
decay can be used to determine the ratio of holo- to apo-forms
of the sensor, but the intensity can only be used to detect the
apo-form of the sensor (because the holo-form of the sensor is
quenched). Sensor designs that rely on measurements of
fluorescence quenching require an additional tag (distant from
the heme-binding pocket and the other chromophore site) to
normalize the signal intensity. (ii) The quantitative accuracy of
fluorescence lifetime imaging or spectroscopy is independent
of the inner filter effect or partial photobleaching of the
fluorescent protein.
Another property of the emission of a fluorescent protein is
the anisotropy (polarization), which might be modulated by
changes in the rotational diffusion between the apo- and holo-
forms of the sensor. The sensitivity of a polarization
measurement will be highly dependent on the local viscosity
and, as yet, it has not been exploited in the context of heme
sensing.
Maintaining Homeostasis in the Presence of Heme
Sensors
The in vivo deployment of a heme sensor in cells introduces an
additional heme-binding species into the cellular milieu. Hence
the sensor will compete with other heme-binding proteins in
the cell for molecules of exchangeable heme. While there
would be no issue with the sensor competing for heme with
either heme-binding proteins, or small molecules, whose roles
are to buffer the concentration of free heme, it is critical that
this competition does not extend to bona fide heme proteins
that require heme either for their function or to adjust their
properties. To accurately measure the availability of heme in
cellular compartments, the expressed sensor must integrate
into the network of buffering partners, and its presence must
not result in a significant change either to the amount of
exchangeable heme (He) associated with these heme-binding
partners, or to the miniscule amount of free heme (Hf) in the
cell. For a certain concentration of exchangeable heme, it is
fairly straightforward to estimate an appropriate range of
concentrations for the sensor that will preserve heme
homeostasis in the cell.77 On the basis of measurements in
the cytosol of HEK293 cells,77 a sensor concentration of up to
1 μM would not be expected to alter the availability of heme
for exchangeable heme concentrations equal to, or in excess of,
3 μM. It is realistic to assume that, if a sensor is deployed in a
localized area of the cell (e.g., directed specifically to the
nucleus), then the sensor concentration may exceed 1 μM.
Hence, we anticipate that, in future, controlling the
concentration of expressed sensor will be increasingly
important.
Summary of Known RET and FRET-Based Heme Sensors
There are a number of reports of different fluorescent heme
sensors in the literature. We summarize them briefly below.
Heme concentrations reported from the studies of these
sensors are given in Table 1.
In the early 2000s, Takeda et al. provided the first proof-of-
concept for a heme sensor. The sensor comprised an EGFP-
cytochrome b562 fusion protein,
176 and it was subsequently
optimized for enhanced RET.177 Fluorescently labeled variants
of heme oxygenase-1 (K18C178 and D140H179 variants) have
also been used to detect heme in vitro. These sensors were a
step forward in terms of heme quantification, but were not
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deployed in cells for real-time monitoring of heme
concentrations.
The first genetically encoded heme sensor was CYSDY-9.76
CISDY-9 was designed to exploit the natural dimerization of a
pair of bacterial chaperones (IsdX1 and IsdC). Tagging each
chaperone with a fluorescent probe and linking them with a
short peptide tether produced an intracellular FRET reporter
which was used to analyze heme population in HeLa cells,
Table 1. With the exception of the endoplasmic reticulum,
heme concentrations were found to be evenly distributed
across the cytosol, the mitochondria and the nucleus, which is
different from the observations in yeast (see above and ref 79).
It may be the case that results from different sensor systems
cannot be directly compared, see Table 1.
Cytochrome b562 was later engineered with EGFP and
mKATE2 fluorescent tags. This created a sensor that could be
deployed in cells79 in which the fluorescence intensity of EGFP
was quenched (via RET) on heme-binding; the intensity of
mKATE2 was unchanged providing a means of assessing heme
concentration by ratiometric analysis. A somewhat heteroge-
neous distribution of heme throughout yeast cells was
reported, Table 1, and the behavior of the sensor in cells112
supported the concept of a (buffered) reservoir of exchange-
able heme that is readily available for regulatory roles and
crucial in the overall physiology of yeast. The same sensor was
then utilized to demonstrate that heme delivery from
mitochondriathe place of heme biosynthesisto the
nucleus was 25% faster than to the cytosol and the
mitochondrial inner matrix. The authors suggested direct
membrane contacts between mitochondria and the ER as a
possible pathway for heme delivery to the nucleus.170,171
A genetically encoded (FRET-based) heme sensor based on
histidine rich protein 2 has been used to quantify heme
concentrations in the parasite P. falciparum.78 In this case,
heme concentrations are higher (ca. 1.6 μM), but this is not
completely unexpected considering that 80% of the amount of
heme contained in a human body is synthesized by red blood
cells.73
Peroxidase-based fluorescent sensors, based on horseradish
peroxidase and ascorbate peroxidase, were first used to
measure dynamic heme fluxes in C. elegans.75 Ascorbate
peroxidase has also been used recently to monitor heme
concentrations and distributions in live cells77 using
fluorescence lifetime imaging microscopy. In this work,
miniscule concentrations (a few nM) of free heme were
identifiedcorresponding to one molecule or less per cellular
compartment. These observations are consistent with a system
that sequesters free heme.
The Use of Heme Sensors to Study Heme Protein
Maturation
Applications of heme sensors can extend beyond the
determination of heme concentrations. A GFP-labeled version
of cytochrome c peroxidase has been recently developed and
used to study heme protein maturation by heme insertion.119
In this design, the percentage of the heme-bound sensor in
yeast cells was revealed by the relative amplitudes of
exponential-decay components in the emission measured by
fluorescence lifetime imaging. This provides a forward-looking
approach to establish in real-time the dynamic processes
involved in the folding process that accompanies the formation
of heme proteins.
Alternative Approaches
There are other technological approaches to heme quantifica-
tion, including the use of the antimalarial 4-aminoquinoline
probe180 and peptide-based fluorescent probes.181 The use of
heme catabolitesbiliverdin and bilirubinas a way of
tracking and studying heme biochemistry is also promising
and is starting to provide interesting insights into the interplay
between the biochemistry of heme and other biological
pathways.182−189
■ POSSIBLE MECHANISMS OF HEME TRANSFER
Detailed information on the mechanism to transfer heme from
one place to anotherfor example between protein partners
is as yet poorly defined. It has been suggested77 that an
exchange mechanism between protein partners might play a
role, as shown in Figure 5. This is envisaged as heme exchange
between a donor, which could be a buffering molecule or a
chaperone, and an acceptor such as a heme protein or a heme
sensor. This heme exchange could take place by a range of
different pathways (corresponding to dissociative or associative
mechanisms) for delivery of heme to specific acceptors. The
existence of such a mechanism, as outlined in Figure 5, would
account for the buffering of the concentration of free heme,
changes in heme availability, and how cells are able to hoard
supplies of heme despite the undesirable effects of heme. It
Figure 5. Possible mechanisms for exchange of heme. Heme-binding
partners (dark gray pacmans) are envisaged as transferring heme to
heme proteins (red circles) by dissociative (pale gray box) or
associative (pale yellow box) pathways, resembling classical ligand
exchange mechanisms in coordination chemistry. In a dissociative
pathway, a free molecule of heme (assumed to be coordinated by a
water molecule) is formed transiently following dissociation from a
heme-binding partner, and is intercepted by an apo-heme protein
(faded red circles). Alternatively, an associative exchange of heme is
possible and is shown here for the example of heme delivery by
chaperones (C, circles). This latter mechanism may provide better
selectivity toward the target heme protein. However, we do not
envisage this as being exclusive to chaperones, but a mechanism
which, in principle, is available to be used by heme-binding partners as
well in delivering heme to apo heme proteins. The different
mechanisms of heme exchange may help to fine-tune the delivery of
heme to specific acceptors.
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would also provide a responsive capability for mobilization of
heme when and where needed.
■ SUMMARY AND FUTURE OUTLOOK
The logistics for the distribution of heme in cells have yet to be
fully discovered. In practice, the dynamic requirements of
cellular supply and demand may be complex, and perhaps
there is no single mechanism for movement of heme within
cells that dominates. Chaperones, heme-binding partners,
membranes, and transporters may well work together in a
concerted way and could provide contingencies for heme
supply under conditions where the cell needs to react quickly
to changes in heme demand. We see the role of a buffered
reservoir of heme-binding proteins, potentially in large
numbers, as being important. This could allow heme to travel
from one place to another, where molecules of heme hitchhike
across the cell by binding to whichever protein(s) they can find
en route to their final destination.
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